Company file
keyboard_backspaceBack to directoryIdentity
tebu-bio
The strength of our distribution activity through the pan-European branches of our group, lies in our longstanding relationships with our suppliers. This allows us to provide first-rate service and to be the reliable source for reagents critical to our customers’ research and product development. In parallel, access to a broad selection of ethical sources, including collections of biological samples and primary cells, enables us to perform in vitro assays for understanding mechanisms of actions (MOA) and demonstrating proofs of concepts (POC) with a short turnaround time.
tebu-bio offers innovative services and research reagents throughout Europe in Life Sciences for biotech companies, pharmaceutical groups and cosmetic companies, as well as CROs and academic institutes. We run functional assays and proof of concepts in drug discovery and target identification, mimicking the physiological environment with in vitro models and suited oxygenation. A wide variety of technologies enables the validation of biomarkers, drug repositionning and quantitative analyses related to RNA therapeutics. Our expertise also covers the production of recombinant proteins and antibodies in prokaryotic and eukaryotic systems, the sourcing of primary cells or tissues (healthy or pathological), as well as RNA synthesis and molecular biology.
Contact
39 rue de Houdan
78610 Le Perray en Yvelines
France
01 30 46 39 00
Activities
- Manufacturer
- Service company
- Target Identification
- Target Identification
- Gene Cloning
- Gene augmentation
- Gene inhibition
- Killing Gene
- KI / KO
- (Gene) engineering
- CRISPR activation
- CRISPR interference
- TRAC gene editing
- TALEN
- Gene Delivery system
- Lentivirus
- Retrovirus
- Adeno-Associated Virus (AAV)
- Adenovirus (ADV)
- Gene Gun
- Electroporation
- Lipid chemical methods
- Protein chemical methods
- Mixed chemical methods
- Inorganic methods
- Bioproduction
- Bioproduction
- Scale-Up
- Automate manufacturing
- Automated high-throughput microbioreactor system
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Cell acquisition
- Autologus
- Allogenic
- Cell Bank
- Tissue acquisition
- Off the shelf
- Apheresis
- Target cell isolation
- iPS reprogrammation
- Differentiated Cell
- Production Cell
- Safety donor-derived therapies
- Cell modification
- Gene modification
- Directed reprogrammation
- Construct introduction
- Purification / extraction
- Purification / extraction
- Targer Identification
- Targer Identification
- Gene Delivery system
- Lentivirus
- Retrovirus
- Adeno-Associated Virus (AAV)
- Adenovirus (ADV)
- Gene Gun
- Electroporation
- Lipid chemical methods
- Protein chemical methods
- Mixed chemical methods
- Inorganic methods
- Biomarker Identificaton
- Biomarker Identificaton
- Adoptive T cell Major Challenges in Solid Tumors
- Tumor/Ag heterogeneity
- Tumor associated Antigen
- Miroenvironment
- Delivery/homing
- Combinations
- Cell modification
- Gene modifcation
- Directed reprogrammation
- Construct introduction
- Cell acquisition
- Autologus
- Allogenic
- Cell Bank
- Tissue acquisition
- Off the shelf
- Apheresis
- Cell modification
- Directed reprogrammation
- Cell Activation
